Canaccord Genuity Assumes Coverage on Optimer Pharmaceuticals (OPTR) at Buy; Near Term Growth Driven by Unmet Need

Go back to Canaccord Genuity Assumes Coverage on Optimer Pharmaceuticals (OPTR) at Buy; Near Term Growth Driven by Unmet Need